Burning Rock Biotech Ltd Ratios

Ratios Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 73.02%71.70%67.47%67.59%70.25%
EBT Margin -94.73%-156.70%-172.08%-121.19%-66.06%
EBIT Margin -95.93%-156.95%-174.07%-124.54%-69.32%
EBITDA Margin -135.87%-164.65%-165.10%-120.85%-66.53%
Operating Margin -95.93%-156.95%-174.07%-124.54%-69.32%
Net Margin -135.87%-164.65%-172.44%-121.63%-67.20%
FCF Margin -31.13%-134.33%-92.12%-49.10%-18.94%
Efficiency
Inventory Average 14.88M19.11M14.31M9.15M
Assets Average 382.85M293.86M188.32M133.88M
Equity Average 330.30M228.76M138.09M93.90M
Invested Capital 376.35M289.94M167.94M108.23M79.57M
Asset Utilization Ratio 0.210.280.400.53
Leverage & Solvency
Interest Coverage Ratio 619.66519.00
Debt to Equity 0.010.00
Debt Ratio 0.010.00
Equity Ratio 0.910.810.730.740.66
Times Interest Earned 619.66519.00
Valuation
Enterprise Value 2,000.05M758.74M99.65M8.51M-1.86M
Market Capitalization 2,355.93M993.35M233.80M95.16M69.68M
Return Ratios
Return on Sales -0.95%-1.57%-1.72%-1.21%-0.65%
Return on Capital Employed -0.39%-0.61%-0.62%-0.50%
Return on Invested Capital -0.38%-0.62%-0.68%-0.51%
Return on Assets -0.33%-0.48%-0.49%-0.34%
Return on Equity -0.38%-0.61%-0.66%-0.49%